EUVIMEDDescubrir EUVIMED
BeobachtungsstudieOpen access · CC BY 4.0

Ocular safety of 222‐nm far‐ultraviolet‐c full‐room germicidal irradiation: A 36‐month clinical observation

Kazunobu Sugihara, Sachiko Kaidzu, Masahiro Sasaki, Sho Ichioka, Ichiya Sano, Katsunori Hara, Masaki Tanito iD

Photochemistry and Photobiology · 2025-09 · 101 (5) · 1343-1349

DOI: 10.1111/php.14052 ↗

At a glance

Beobachtungsstudie in Photochemistry and Photobiology, published online on 2024-12-10. Written by Kazunobu Sugihara and 6 co-authors. Institution: Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan. Major MEDLINE topics: Ultraviolet Rays, Eye. Cited 16 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ushio Inc..

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

The ocular safety of 222‐nm far‐ultraviolet‐C (UV‐C) irradiation, widely recognized for its germicidal properties, was evaluated in a clinical setting to assess its long‐term health effects on the human eye. This prospective observational study involved a 36‐month follow‐up of physicians working in an ophthalmic examination room equipped with 222‐nm UV‐C lamps. Initially, a 12‐month observation showed no signs of acute or chronic ocular damage. To further substantiate these findings, the study period was extended to 36 months, during which four participants underwent regular ocular examinations, including assessments of visual acuity, refractive error, and corneal endothelial cell density. The irradiation dose was meticulously controlled to remain within the previous threshold limit of 22 mJ/cm 2 over an 8‐h period, as advised by the ACGIH prior to 2022. Results indicated no significant changes in these parameters, suggesting no clinically significant ocular hazards associated with prolonged exposure to 222‐nm UV‐C irradiation under real‐world conditions. Additionally, no delayed side effects, such as pterygium, keratopathies, or cataracts, were observed. Our study supports the safe use of 222‐nm UV‐C for microbial disinfection in occupied environments and provides a robust foundation for updated safety guidelines.

Subjects

MeSH terms (MEDLINE)

Ultraviolet RaysEyeHumansProspective StudiesMaleFemaleMiddle AgedAdultVisual Acuity

Author keywords

222 nm excimer lampclinical trialfull‐room ultraviolet germicidal irradiation (UVGI)health hazardocular safety

Authors and institutions

  • Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan.
  • Ushio Inc., Tokyo, Japan.

ORCID profiles: Masaki Tanito

Funding

  • Ushio Inc.

Cite

APA

Sugihara, K., Kaidzu, S., Sasaki, M., Ichioka, S., Sano, I., Hara, K., & Tanito, M. (2025). Ocular safety of 222‐nm far‐ultraviolet‐c full‐room germicidal irradiation: A 36‐month clinical observation. Photochemistry and Photobiology, 101(5), 1343-1349. https://doi.org/10.1111/php.14052

Vancouver

Sugihara K, Kaidzu S, Sasaki M, Ichioka S, Sano I, Hara K, et al. Ocular safety of 222‐nm far‐ultraviolet‐c full‐room germicidal irradiation: A 36‐month clinical observation. Photochemistry and Photobiology. 2025;101(5):1343-1349. doi:10.1111/php.14052

BibTeX
@article{Sugihara2025,
  author = {Sugihara, Kazunobu and Kaidzu, Sachiko and Sasaki, Masahiro and Ichioka, Sho and Sano, Ichiya and Hara, Katsunori and Tanito, Masaki},
  title = {Ocular safety of 222‐nm far‐ultraviolet‐c full‐room germicidal irradiation: A 36‐month clinical observation},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  volume = {101},
  number = {5},
  pages = {1343--1349},
  doi = {10.1111/php.14052}
}
Start for free →